Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Staphylococcus aureus Infections

Journal Article · · ACS Infectious Diseases

Many bacterial pathogens, including Staphylococcus aureus, require inosine 5'-monophosphate dehydrogenase (IMPDH) for infection, making this enzyme a promising new target for antibiotics. Although potent selective inhibitors of bacterial IMPDHs have been reported, relatively few have displayed antibacterial activity. Here we use structure-informed design to obtain inhibitors of S. aureus IMPDH (SaIMPDH) that have potent antibacterial activity (minimal inhibitory concentrations less than 2 μM) and low cytotoxicity in mammalian cells. The physicochemical properties of the most active compounds were within typical Lipinski/Veber space, suggesting that polarity is not a general requirement for achieving antibacterial activity. In this work, five compounds failed to display activity in mouse models of septicemia and abscess infection. Inhibitor-resistant S. aureus strains readily emerged in vitro. Resistance resulted from substitutions in the cofactor/inhibitor binding site of SaIMPDH, confirming on-target antibacterial activity. These mutations decreased the binding of all inhibitors tested, but also decreased catalytic activity. Nonetheless, the resistant strains had comparable virulence to wild-type bacteria. Surprisingly, strains expressing catalytically inactive SaIMPDH displayed only a mild virulence defect. Collectively these observations question the vulnerability of the enzymatic activity of SaIMPDH as a target for the treatment of S. aureus infections, suggesting other functions of this protein may be responsible for its role in infection.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); USDOE Office of Science (SC)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1854352
Journal Information:
ACS Infectious Diseases, Journal Name: ACS Infectious Diseases Journal Issue: 11 Vol. 7; ISSN 2373-8227
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (57)

Physiological concentrations of purines and pyrimidines journal January 1994
Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors journal August 1969
N.m.r. studies of d-ribosylamines in solution: Derivatives of primary amines journal February 1983
The identification of the two crystalline N-phenyl-d-ribosylamines (“ribose anilides”) by n.m.r. spectroscopy journal September 1981
High-performance liquid chromatographic methods for base and nucleoside analysis in extracellular fluids and in cells journal December 1981
Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH journal March 2012
Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV journal August 2012
Phthalazinone inhibitors of inosine-5′-monophosphate dehydrogenase from Cryptosporidium parvum journal February 2013
Carbohydrate-based inducers of cellular stress for targeting cancer cells journal March 2016
IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex journal January 2017
Structural Determinants of Inhibitor Selectivity in Prokaryotic IMP Dehydrogenases journal October 2010
Evolving medicinal chemistry strategies in antibiotic discovery journal December 2016
Synthesis and Structure–Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH journal July 2019
Mutation of purD and purF genes further attenuates Brucella abortus strain RB51 journal February 2015
Fragment-Based Approach to Targeting Inosine-5′-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis journal March 2018
Expanding Benzoxazole-Based Inosine 5′-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents journal May 2018
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis journal September 2016
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis journal October 2016
The Bare Essentials of Antibiotic Target Validation journal November 2016
Bacillus anthracis Inosine 5′-Monophosphate Dehydrogenase in Action: The First Bacterial Series of Structures of Phosphate Ion-, Substrate-, and Product-Bound Complexes journal July 2012
The Structural Basis of Cryptosporidium-Specific IMP Dehydrogenase Inhibitor Selectivity journal February 2010
Selective and Potent Urea Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase journal September 2012
Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase journal May 2013
Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents journal October 2013
Synthesis, in Vitro Evaluation and Cocrystal Structure of 4-Oxo-[1]benzopyrano[4,3- c ]pyrazole Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase ( Cp IMPDH) Inhibitors journal December 2014
Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens journal November 2014
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery journal May 2008
Triazole Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase journal August 2009
Repurposing Cryptosporidium Inosine 5′-Monophosphate Dehydrogenase Inhibitors as Potential Antibacterial Agents journal June 2014
Mapping the Protein Interaction Network in Methicillin-Resistant Staphylococcus aureus journal March 2011
Metabolite concentrations, fluxes and free energies imply efficient enzyme usage journal May 2016
General and condition-specific essential functions of Pseudomonas aeruginosa journal April 2015
The purine biosynthesis regulator PurR moonlights as a virulence regulator in Staphylococcus aureus journal June 2019
A Novel Cofactor-binding Mode in Bacterial IMP Dehydrogenases Explains Inhibitor Selectivity journal January 2015
A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis journal March 2009
FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery journal July 2017
Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates journal May 2015
Identification of novel diphenyl urea inhibitors of Mt-GuaB2 active against Mycobacterium tuberculosis journal January 2011
A fine scale phenotype-genotype virulence map of a bacterial pathogen journal July 2012
Structure of Cryptosporidium IMP dehydrogenase bound to an inhibitor with in vivo antiparasitic activity journal April 2015
The CBS subdomain of inosine 5′-monophosphate dehydrogenase regulates purine nucleotide turnover: CBS subdomain of IMPDH journal February 2008
Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis journal October 2017
Efficacy of Novel Rifamycin Derivatives against Rifamycin-Sensitive and -Resistant Staphylococcus aureus Isolates in Murine Models of Infection journal November 2006
New Vector for Efficient Allelic Replacement in Naturally Nontransformable, Low-GC-Content, Gram-Positive Bacteria journal November 2004
Genome-Wide Identification of Genes Required for Fitness of Group A Streptococcus in Human Blood journal March 2013
De Novo Guanine Biosynthesis but Not the Riboswitch-Regulated Purine Salvage Pathway Is Required for Staphylococcus aureus Infection In Vivo journal July 2016
Complete Bypass of Restriction Systems for Major Staphylococcus aureus Lineages journal May 2015
Genome-Wide Identification of Klebsiella pneumoniae Fitness Genes during Lung Infection journal July 2015
Genome-Wide Identification of Acinetobacter baumannii Genes Necessary for Persistence in the Lung journal June 2014
Genes Contributing to Staphylococcus aureus Fitness in Abscess- and Infection-Related Ecologies journal October 2014
Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis journal January 2017
Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria journal June 2015
Two Classes of Bacterial IMPDHs according to Their Quaternary Structures and Catalytic Properties journal February 2015
Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds journal October 2015
High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism journal September 2011
Antibiotic resistance threats in the United States, 2019 report January 2019
The Antibiotic Potential of Prokaryotic IMP Dehydrogenase Inhibitors journal May 2011

Similar Records

Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.
Journal Article · Thu Dec 31 23:00:00 EST 1998 · Biochemistry · OSTI ID:942430

Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim
Journal Article · Thu Sep 02 00:00:00 EDT 2010 · Proteins · OSTI ID:1006143

Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureus
Journal Article · Sat Sep 06 00:00:00 EDT 2014 · European Journal of Medicinal Chemistry · OSTI ID:1160044